BIG PHARMA IN FREE-FALL – The Biggest & Fastest Wipe-Out of an Entire Industry In History? – Century of Crimes? - Warning to Governments – Transforming China’s Economy – Belt &Road Forum - [10-22-23]
Direct from BOOM Finance and Economics at the links below
Hat Tip to my colleague at: BOOM Finance and Economics Substack (Subscribe for Free) - also on LinkedIn and WordPress. Covid Medical News Network CMN News BOOM Blog and All Editorials (over 5 years) at: BOOM Finance and Economics | Designed for Critical Thinkers — UPDATED WEEKLY (WordPress.com)
BOOM Finance and Economics seeks out the very best information from authoritative sources and strives for consistency in its quality and trustworthiness. Over 5 years, BOOM has developed a loyal readership which includes many of the world’s most senior economists, central bankers, their senior advisers, fund managers and academics. If you want a real edge in understanding the complex world of finance and economics, subscribe to BOOM on Substack or as a Follower on LinkedIn.
BOOM EDITORIAL THIS WEEK
COVID COMPANIES IN FREE FALL – IS THIS THE BIGGEST AND FASTEST WIPE OUT OF AN ENTIRE INDUSTRY IN HISTORY? — MRNA TECHNOLOGY COLLAPSE
Over the last week, the selling has continued in the Biotech/Pharma companies involved in manufacturing Covid vaccines. Investors are rapidly leaving the sinking ships. Pfizer shares got off lightly. They fell by (only) 4.55% during the week. They are down 48% since their high in late 2021.
MODERNA SHARES DOWN OVER 18% IN JUST ONE WEEK - However, Moderna shares were slammed by 18.21% during the week’s trade. They are down 84% since their high in August 2021:
And the German company Biontech SE was also hammered last week on Wall Street – down 12.23%. It is now down a staggering 80% from its high in August 2021.
NOVAVAX HAS FALLEN BY 98% - Last but not least, last week, Novavax (NVAX) fell by another 8.8% when it hit a Low of $6.00. In February 2021, its price hit a high of $ 325!
Many experts argue that the Novavax Covid “vaccine” is actually the preferable product among the group because it does not contain any foreign, man-made, synthetic genetic material. Thus, it cannot be called a “Gene Therapy” drug or “Gene Technology”. It (supposedly) only contains purified Spike Protein against which the immune system can react.
The foreign, synthetic, man-made protein, however, is still bound to a potentially harmful lipid nanoparticle for its distribution in the blood stream. There is also a Matrix (M1) adjuvant which is a potent immune stimulant. Matrix M1 is made from a soap-like complex sugar (saponin) that comes from the bark of a tree; some lipid is added to this so it can combine with the Spike protein nanoparticles. Despite all this, the shares of Novavax have fallen from its high of US$325 to its current US$6.00 Low.
If the Best-in-Class of the group can fall by 98%, the question must be asked, can the others fall by similar amounts? If so, it is possible that we may be looking at the biggest (and fastest) wipe-out in share market history for an entire new “gee whiz”, “high tech”, “promising” industry. More than 18 months ago, on January 22nd 2022, the BOOM editorial stated,
“On the Covid genetic injection therapies, Professor Christian Perronne stated in France last week, these are not vaccines”. “The biggest scandal of this epidemic is that we have been made to believe these are 'vaccines'. They are not vaccines at all." He should know. He is a super expert on vaccines.
Then, on 19th February 2022, BOOM wrote this — “There are many medical and scientific doubts forming about the medium and long term safety and efficacy of the new mRNA technology injectables being used globally as primary (only?), Covid policy by many governments.
These products are clearly not vaccines in the conventional sense as they do not prevent infection and they do not stop transmission of the virus.” And “BOOM expects these stocks to struggle to make gains to higher levels. Price downtrends appear to be well established and the fundamental future outlook for this technology looks clouded in doubt.”
On 19th June 2022, BOOM again, "If it can be proved that these companies understood that this new technology was potentially dangerous prior to signing the agreements, then future governments will possibly be inclined towards denying the contracts. BOOM is certainly not a lawyer but this all looks rather tenuous to the layman. After all, even the non-lawyer layman can see the rationale for the agreements in the first place was one of attempting to circumvent future bad outcomes.”
Most everyone on Earth now knows that Covid mRNA vaccines do not fully protect users from being infected with Covid and they do not fully stop them from possibly transmitting the virus to other people. So the word “vaccine” is now arguably not relevant to this product. There appears to be evidence that the companies themselves did not call the products “vaccines” during their development and in their FDA applications.
“When companies sell products that fail to deliver the promised purposes for which they were sold, then it can be argued that they may have committed a fraud and legal challenges could inevitably flow. If a company pre-sold a plane that could not fly, then the fraud would be obvious. No pre-agreement based upon the presumption of safe flight could negate this.”
And concerning Pfizer’s cash holdings, “Pfizer’s huge cash buffer may not be enough if a determined class action is brought by many millions of people claiming to be damaged in some way by the product itself (adverse reactions) or by the product’s failure to protect against acute Covid infection and/or the longer term outcome now known as Long Covid.”
“A major class action legal challenge where many, many $ Billions or $ Trillions of damages could be awarded by adverse court decisions would then threaten the very existence and survivability of the company. As previously explained, any future government could theoretically renege on any immunity agreement entered into by a previous government.”
On August 20th 2022 — “When the Pfizer and Moderna trial study results were released in December 2020, BOOM calculated the Absolute Risk Reduction in the trials to be 0.8% – 1.3%. It seemed obvious that the product was not going to provide any significant protection from the infection on a population basis. Of course, the politicians sold it as “95% effective” which reflects a Relative Risk Reduction. BOOM knew that this was disingenuous”.
On 19th August 2023 — “Over the last two years, billions of people (and their children) in many nations were coerced through extensive government and media Covid fear campaigns, government mandates and employer mandates into having an injection of mRNA technology into their arms. We now know that those Covid vaccines were not previously tested for prevention of viral transmission.”
On 28th August 2023 — “BOOM thinks the market is screaming at us to avoid these companies that are promising to create a “revolution in biotechnology and healthcare”.
CRIME OF THE CENTURY? - BOOM readers have been well informed on this matter over the last two years since the “vaccines” were released onto an unsuspecting public by companies and governments declaring that they were, “safe and 95% effective”. Such statements may well go down in history as the greatest and most dangerous lies ever foisted onto trusting citizens.
It may then be recognised as the greatest crime against humanity in all of history. A recent estimate by Canadian Professor of Physics, Denis Rancourt, of 17 million deaths caused by these Gene Technology products may well be proved accurate in the fullness of time. The number of people rendered disabled by illness could be orders of magnitude greater.
From Rancourt’s recent detailed analysis of 17 nations — “In the 17 countries, there is no evidence in all-cause mortality (ACM) by time data of any beneficial effect of COVID vaccines. There is no association in time between COVID vaccination and any proportionate reduction in ACM. The opposite occurs.” Available for Download as a PDF:
WARNING TO ALL GOVERNMENTS- Governments in the UK and Australia must take note as they are currently planning to assist these companies in building mRNA manufacturing facilities. Foolish politicians have rushed in where wiser governments have thoughtfully feared to tread.
According to Press Releases, the Australian Government has proudly announced plans to invest up to A$25mn from 2022–23 in its 'mRNA Clinical Trials Enabling Infrastructure Grant Opportunity'
“This funding will support Australian medical research and medical innovation projects that use emerging technologies, platforms, equipment and infrastructure to conduct clinical trials of mRNA-based vaccines and therapeutics.” The grant opportunity forms part of the Government’s Coronavirus Research Response. It is funded through the A$20bn Medical Research Future Fund.
The Australian State Government of Victoria has announced, “The (mRNA) manufacturing facility will be capable of producing up to 25 million vaccine doses per year from 2024, with the capacity to scale up to 100 million doses per year to combat future pandemics”.
100 Million doses in a nation of just 25 million people. What are these politicians smoking?
In the UK, the government is also charging ahead into a possible cataclysm. It reminds BOOM of the famous Charge of the Light Brigade, often described as reckless. They have proudly announced, “Moderna’s state-of-the-art mRNA Innovation and Technology Centre will produce up to 250 million vaccine doses a year. The large-scale manufacturing facility aims to provide UK National Health Service (NHS) patients with constant access to Covid-19 vaccines and other next-generation of mRNA vaccines and treatments.” Constant access to 250 million doses per year for a population of 67 million. Huh?
Rushes of blood to the head are one thing. Time to consider some pertinent facts.
INCREASED CANCER RISK SAYS JAPANESE PROFESSOR MURAKAMI - It is worth checking what BOOM wrote in the editorial on 11th June 2023. In retrospect, it is chilling. Long term BOOM readers will remember this:
“BOOM is certainly not an expert in vaccines or in molecular biology. BOOM is not a virologist. But BOOM can read. And BOOM recently read this on a website provided by Dr Mark Trozzi in Canada. It may not be true. BOOM cannot tell. But, if it is, then it is a cause for major concern as it has been reported that 5.55 billion people have received at least one Covid vaccine shot. That is 72% of the global population.”
“Professor Murakami expresses concerns over the alarming discovery of Simian Virus 40 (SV40) promoters, associated with human cancer development, in DNA plasmids within Pfizer vials.”
“The Pfizer vaccine has a staggering problem. I have made an amazing finding. This figure is an enlarged view of Pfizer’s vaccine sequence. As you can see, the Pfizer vaccine sequence contains part of the SV40 sequence here. This sequence is known as a promoter. Roughly speaking, the promoter causes increased expression of the gene. The problem is that the sequence is present in a well-known carcinogenic virus”.
“The question is why such a sequence that is derived from a cancer virus is present in Pfizer’s vaccine. There should be absolutely no need for such a carcinogenic virus sequence in the vaccine. This sequence is totally unnecessary for producing the mRNA vaccine. It is a problem that such a sequence is solidly contained in the vaccine. This is not the only problem. If a sequence like this is present in the DNA, the DNA is easily migrated to the nucleus.”
“So it means that the DNA can easily enter the genome. This is such an alarming problem. It is essential to remove the sequence. However, Pfizer produced the vaccine without removing the sequence. That is outrageously malicious. This kind of promoter sequence is completely unnecessary for the production of the mRNA vaccine. In fact, SV40 is a promoter of cancer viruses.”
BOOM suggests that readers carefully consider the contents of the following editions of CMNnews:
Special Edition October 10, 2023: Are Covid Vaccines GMO’s? And are they Contaminated with Foreign DNA. And Turbo Cancer Warning October 17, 2023
TRANSFORMING CHINA’S ECONOMY - On 27th August, BOOM wrote, “BOOM advises readers to ignore the “China collapse” stories and the “US Dollar collapse” stories. This will leave much time to read more suitable analyses.”
And on 19th August — “BOOM’S leading economic indicator for China has stabilised and is no longer falling as it was during June and July.”
BOOM has often referred to that special indicator which for years has been a reliable tracker of the wellness of the Chinese economy. Since August, however, the indicator has continued to decline to its lowest level in two years and that has alerted BOOM to take a closer look.
It is important to understand that the indicator is heavily weighted towards the concept of China’s economy being principally a mercantile one. A mercantilist economy is one that depends very much upon the export of goods to willing foreign customers in return for US Dollar settlement, the so-called dominant reserve currency.
BOOM is now of the opinion that China is rapidly re-positioning its economy away from that model. It has moved towards a policy of discouraging personal wealth creation which will re-balance wealth disparities among its citizens. And it has decided that its future is one that is not tied to earning US Dollars in return for exporting manufactured goods to the advanced economies of the West.
In other words, China has begun to concentrate on building up the resilience of its internal, domestic economy which has 1.5 billion consumers and also on building closer connections with its neighbours (especially Russia). It has also increased connections to its Belt & Road partners and to partner nations in the BRICS group of nations. All this makes good sense because another 1.5 billion consumers (or more) reside in those nations.
In summary, 3-4 billion consumers await China’s future promise of consumer goods. And they will pay for those goods with a mix of their own currencies and the Chinese currency. Currency multi-polarity is the aim.
China’s major input into its economy is energy and it must import most of this in the form of oil, natural gas, and coal. The growing alliances with Russia and Saudi Arabia will provide that energy in return for settlement in Chinese Yuan, Russian Rubles and Saudi Riyals. In other words, Russia and Saudi Arabia will be increasingly happy to receive currencies from China other than US Dollars in return for their energy exports.
Saudi Arabia desperately needs food and water for its population of 32 million people. That will be provided by Russia via food exports plus nuclear power plants which will provide the energy for increased desalination plants. The fresh water will support Saudi Arabia’s animal herds and thus its protein supply. The goal is Self-sufficiency for each nation.
RUSSIAN AND CHINESE CURRENCIES SEEM TO HAVE STABILISED AGAINST US DOLLAR AND SAUDI RIYAL - This year, since July, the Chinese Yuan seems to have stabilised around 7.3 Yuan to the US Dollar:
The Russian ruble also seems to have stabilised since July, as per BOOM’s stated expectations, around 95-100 rubles/ US Dollar.
And the Saudi currency has been officially pegged to the IMF’s special drawing rights (SDRs) since 1986. In practice, it’s fixed at 1USD = 3.75 riyals. Thus, the Saudi Riyal is essentially fixed to the US Dollar but kept in a tight trading range by the Saudi central bank.
BOOM is expecting these relative price levels to be actively maintained. In this way, stability between all three currencies will create a reliable basket of currencies for other nations to recognise. The US Dollar ultimately becomes relatively peripheral to such an arrangement.
On 3rd September, BOOM made the following statement concerning the Russian ruble versus the US Dollar — “Does this mean that the Russian central bank has drawn a line in the sand at 100? Possibly.” It looks like we can now change that last word to “Probably”.
If these three currency relativities can be maintained, then the future pathway for all three economies will be Self re-enforcing. A virtuous circle will have been established.
Central to all this is China’s need for energy, food, minerals, and water to support its population of 1.5 billion people. Saudi Arabia’s need for water and food will also be satisfied. And Russia, the land of abundant food, water, minerals and energy will have its security underwritten by China. All this dovetails nicely with other nations in the BRICS group.
BELT & ROAD FORUM — MEETING IN BEIJING - Last week, while the US was distracted by events in the Ukraine and Israel, the President of China, Xi Jing Ping, met with the leaders of many nations connected through the Belt & Road initiative to celebrate the 10th anniversary of the project.
Xi talked of, “an open, inclusive and interconnected world”. According to a report from the American ABC News network, his keynote speech criticised those who view “others’ development as a threat” and “economic interdependence as a risk.” He said that protectionist actions like those the US has taken against China, “will not make one’s own life better or speed up one’s development.” And he stated China’s position very strongly when he said, “We stand against unilateral sanctions, economic coercion and decoupling”.
Xi made that speech to representatives from more than 130 countries assembled in Beijing for the Belt & Road Forum. The special guest of honour was Vladimir Putin, the President of Russia. Twenty Heads of State were present including Indonesia, Thailand, Cambodia, Laos, Kenya, Hungary, Kazakhstan, Argentina, and Chile. The Secretary-General of the United Nations, António Guterres, was also present.
In his speech, Putin made the following pointed statement — “Russia and China, like most countries of the world, share the aspiration for equal and mutually beneficial cooperation in order to achieve universal sustainable and long-term economic progress and social well-being while respecting the diversity of civilisation and the right of each state to its own development model”.
The List of Notable Attendee nations included Argentina and Chile from South America, Egypt, Hungary, Indonesia, Pakistan, Russia, Sri Lanka, and Thailand.
Argentina: President Alberto Fernández
Cambodia: Prime Minister Hun Manet
Chile: President Gabriel Boric
Congo: President Denis Sassou Nguesso
Egypt: Prime Minister Mostafa Madbouly
Ethiopia: Prime Minister Abiy Ahmed
Hungary: Prime Minister Viktor Orbán
Indonesia: President Joko Widodo
Kazakhstan: President Kassym-Jomart Tokayev
Kenya: President William Ruto
Laos: President Thongloun Sisoulith
Mongolia: President Ukhnaagiin Khürelsükh
Mozambique: Prime Minister Adriano Maleiane
Pakistan: Prime Minister Anwaar ul Haq Kakar
Papua New Guinea: Prime Minister James Marape
Russia: President Vladimir Putin
Sri Lanka: President Ranil Wickremesinghe
Thailand: Prime Minister Srettha Thavisin
BOOM’s QUANTITATIVE BOOSTING FOR THE PEOPLES MONEY EXPLAINED: https://boomfinanceandeconomics.wordpress.com/2019/12/15/boom-as-at-15th-december-2019/ AND BOOM’s Perfect Economy: https://boomfinanceandeconomics.wordpress.com/2020/01/18/boom-as-at-19th-january-2020/
In economics, things work until they don’t. Make your own conclusions, do your own research. BOOM does not offer investment advice.
CLICK HERE FOR PODCASTS: OUR BRAVE NEW ECONOMIC WORLD
BANKS DON’T TAKE DEPOSITS, THEY BORROW YOUR MONEY: LOANS CREATE DEPOSITS — that is how almost all new money is created in the economy (by commercial banks making loans). https://www.bankofengland.co.uk/quarterly-bulletin/2014/q1/money-creation-in-the-modern-economy. Watch this short 15-minute video and see how Professor Richard Werner brilliantly explains how global banking systems really work.
In 2014, Richard Werner provided the first empirical evidence that banks create credit out of thin air. They do this whenever they issue a loan or, more specifically, purchase a promissory note. This is a walk-through of exactly how they do it.
Most economists are unaware of this and even ignore the banking & finance sectors in their econometric models.
DISCLAIMER: All content is presented for educational and/or entertainment purposes only. Under no circumstances should it be mistaken for professional investment advice, nor is it at all intended to be taken as such. The commentary and other contents simply reflect the opinion of the authors alone on the current and future status of the markets and various economies. It is subject to error and change without notice. The presence of a link to a website does not indicate approval or endorsement of that web site or any services, products, or opinions that may be offered by them.
Neither the information nor any opinion expressed constitutes a solicitation to buy or sell any neither securities nor investments. Do NOT ever purchase any security or investment without doing your own and sufficient research. Neither BOOM Finance and Economics.com nor any of its principals or contributors are under any obligation to update or keep current the information contained herein. The principals and related parties may at times have positions in the securities or investments referred to and may make purchases or sales of these securities and investments while this site is live. The analysis contained is based on both technical and fundamental research.
Although the information contained is derived from sources which are believed to be reliable, they cannot be guaranteed.
Disclosure: We accept no advertising or compensation, and have no material connection to any products, brands, topics or companies mentioned anywhere on the site.
Fair Use Notice: This site contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available in our efforts to advance understanding of issues of economic and social significance. We believe this constitutes a ‘fair use’ of any such copyrighted material as provided for in section 107 of the US Copyright Law. In accordance with Title 17 U.S.C. Section 107, the material on this site is distributed without profit. If you wish to use copyrighted material from this site for purposes of your own that go beyond ‘fair use’, you must obtain permission from the copyright owner.
Investors are expecting a LOT of suing, so they are pulling their money out. Yeah, greedy bstards that invested in pharma should all get some heavy cloting as far as I'm concerned
If this were only true, most big-pharma stocks seem to be doing well